ClinicalTrials.Veeva

Menu

MDR Vivacit-E Elevated Study

Zimmer Biomet logo

Zimmer Biomet

Status

Invitation-only

Conditions

Fracture of Pelvis
Protrusio Acetabuli
Diastrophic Variant
Avascular Necrosis of Bone of Hip
Fused Hip
Slipped Capital Femoral Epiphyses
Traumatic Arthropathy-Hip
Osteoarthritis (OA) of the Hip

Treatments

Device: Vivacit-E Elevated Liners

Study type

Observational

Funder types

Industry

Identifiers

NCT07150221
MDRG2017-89MS-106H

Details and patient eligibility

About

The main objective of this study is to confirm long-term safety, performance, and clinical benefits of the Vivacit-E Vitamin E HXLPE Elevated Liners when used in primary total hip arthroplasty.

Enrollment

52 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient was 18 years of age or older and skeletally mature at the time of surgery
  • Patient qualified for and underwent surgical procedure with a Vivacit-E Vitamin E HXLPE Elevated Liner to treat one of the following indications in primary THA:
  • Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis
  • Protrusio acetabuli
  • Traumatic arthritis
  • Slipped capital epiphysis
  • Fused hip
  • Fracture of the pelvis
  • Diastrophic variant
  • Patient underwent surgical procedure 10 years (+ no maximum/- 182 days) prior to date of study consent
  • Patient is will and able to sign IRB approved Informed Consent Form or provide verbal consent

Exclusion criteria

  • Off label use or not according to the approved IFU at the time of surgery

  • Patient presented with any of the following at the time of the surgical procedure:

  • Osteoradionecrosis

  • Neuromuscular compromise, vascular deficiency or other conditions in the affected limb that may lead to inadequate skeletal fixation

  • Systemic or local infection

  • Revision procedure where other treatment or devices have failed*

  • Patient has a psychiatric illness or cognitive deficit that will not allow for proper informed consent

  • Uncooperative patient or patient with neurologic disorders who is incapable or unwilling to follow directions

    • For the purpose of this clinical study; a revision procedure refers to a procedure in which the prior procedure on the ipsilateral hip utilized a similar approach (i.e., primary total hip arthoplasty)

Trial design

52 participants in 1 patient group

Vivacit-E Elevated Liners
Description:
Patients previously implanted with Vivacit-E Elevated Liners.
Treatment:
Device: Vivacit-E Elevated Liners

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems